Product Images Azacitidine

This text appears to be describing the results of a statistical analysis, likely related to medical research. A Log-Rank p-value of 0.0001 and a Hazard Ratio of 0.58 are presented alongside a confidence interval of 95% and counts of deaths for two groups: Aza with 82 deaths and CCR with 113 deaths. There is also a graph showing the distribution of patients over time, and two groups represented by the labels "AZA" and "CCR."*

This is a description of a pharmaceutical product, specifically an injection called NOVAPLUS. It is for subcutaneous and intravenous use only and should be kept out of reach of children. The text mentions a dosage of 100mg and indicates that it is a single-dose injection. The manufacturer is based in Germany and there is a contact phone number provided.*

This appears to be product information related to a medication called Azacitiding. It is manufactured by Bartor Oncology GmbH in Germany and is intended for subcutaneous and intravenous use only. The packaging includes a sterle sngl-dose vial containing 100mg of Azacitiding and 100mg of Mannitol. The product is only available with a prescription. The text also includes information related to batch and lot numbers as well as registration information for the trademarks "NOVAPLUS" and "N".*